Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer's disease.
about
Alzheimer's therapeutics: translation of preclinical science to clinical drug developmentEffectiveness and Safety of MLC601 in the Treatment of Mild to Moderate Alzheimer's Disease: A Multicenter, Randomized Controlled Trial.Galantamine treatment in Alzheimer's disease: response and long-term outcome in a routine clinical setting.Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis.Identification of the optimal cognitive drugs among Alzheimer’s disease: a Bayesian meta-analytic review
P2860
Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer's disease.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer's disease.
@ast
Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer's disease.
@en
type
label
Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer's disease.
@ast
Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer's disease.
@en
prefLabel
Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer's disease.
@ast
Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer's disease.
@en
P2860
P1476
Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer's disease
@en
P2093
Maysoon M LouLou
Nathan Herrmann
P2860
P577
2003-01-01T00:00:00Z